Vanderbilt researchers to discuss heart disease, treatment at lectureSep. 17, 2015, 9:30 AM
Three Vanderbilt University researchers on the cutting edge of discovery will discuss the “human determinants of cardiovascular disease and treatment” during the next Flexner Discovery Lecture on Sept. 24.
The lecture will be held from 4 to 5:30 p.m. in room 208 Light Hall. It is sponsored by the Office of the Vice Chancellor for Health Affairs.
The panelists are:
• David Bader, Ph.D., Gladys Parkinson Stahlman Professor of Cardiovascular Research and professor of Medicine and of Cell and Developmental Biology;
• Nancy Brown, M.D., Hugh Jackson Morgan Professor of Medicine and Pharmacology, chair of the Department of Medicine, and physician-in-chief of Vanderbilt University School of Medicine; and
• Thomas Wang, M.D., Gottlieb C. Friesinger II Professor of Cardiovascular Medicine, director of the Division of Cardiovascular Medicine, and physician-in-chief of the Vanderbilt Heart and Vascular Institute.
Bader, a fellow of the American Association for the Advancement of Science (AAAS), is nationally known for furthering the understanding cardiac development.
Brown, also a AAAS fellow who was elected to the Institute of Medicine last year, has made major contributions to the fields of vascular biology and hypertension.
Wang’s research interests include mechanisms of obesity-related cardiac dysfunction, the effects of vitamin D on the heart and identification of novel cardiometabolic markers.
For a complete schedule of the Flexner Discovery Lecture series and archived video of previous lectures, go to www.mc.vanderbilt.edu/discoveryseries.